Merck Reportedly in Advanced Talks to Acquire Harpoon Therapeutics for $700 Million

Merck in Talks to Buy Harpoon Therapeutics for About $700 Million: SourcesMerck & Co. is in advanced talks to acquire Harpoon Therapeutics, a producer of cancer-fighting drugs, for approximately $700 million, according to people familiar with the matter. The discussions, which are ongoing, could lead to an agreement being announced within days if negotiations don’t fall apart, said the people, who asked not to be identified as the information isn’t public. Merck is discussing a deal to buy South San Francisco-based Harpoon at roughly $23 per share, the people said. A representative for Merck declined to comment. A spokesperson for Harpoon didn’t immediately respond to a request for comment on Sunday. (Sina Finance)Original Link